Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1+
SponsorUniversity of Milano Bicocca
About this trial
Autoimmune Hepatitis (AIH) is chronic fibroinflammatory disease of the liver characterized by chronic, relapsing liver inflammation, and a risk for progression to liver failure and need for liver transplantation. No AIH-specific registry does exist in Italy, so that the actual epidemiology of the disease in the country is unknown.
This is an observational, retrospective and prospective, multicenter study evaluating incidence, prevalence and disease course of AIH in subjects \> 1 years old in Italy.
Eligibility criteria
Qualifiers
All AIH patients living in Italy and aged at least 1 year can be included in the database.
Willing and able to give informed consent prior to any study specific procedure being
Diagnosis of AIH according to the most recent published guidelines (EASL)
Disqualifiers
Subject unwilling to participate at the study
Trial design
Treatments tested in this trial
- Clinical Information
Treatment groups
10,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov